United States · FDA National Drug Code directory
Zonisamide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-379_b43ac632-68f3-43f6-aa79-41429a54e1ef
- Product NDC
- 59651-379
- Form
- CAPSULE
- Composition / generic term
- Zonisamide
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200817
- Source listing expiry
- 20271231
Source-listed ingredients
- ZONISAMIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (59651-379-01) · 59651-379-01
- 30 CAPSULE in 1 BOTTLE (59651-379-03) · 59651-379-03
- 500 CAPSULE in 1 BOTTLE (59651-379-05) · 59651-379-05
- 60 CAPSULE in 1 BOTTLE (59651-379-60) · 59651-379-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →